CD8A and neoplasm: This blockade of glutamine metabolism is further highlighted by the metabolic plasticity of tumor-infiltrating CD8+ effector T cells that, unlike cancer cells, are able to detour glutamine antagonism by inducing metabolic reprogramming toward oxidative phosphorylation [122].